1 Product identity
Ingredient risk
1 ingredient to use with caution
CX8
BrandXtendlife→Other Combinations Capsule 15 ingredients 1 caution DSLD #283355Net contents: 90 Vegetarian Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2023-03-22
2 Ingredients (15)
IngredientGroupSafety
CaloriesCalories—
Total CarbohydratesCarbohydrate—
DeltaGold Tocotrienol ComplexBlend—
RutinRutin—
Oxi-fendBlack Currant—
Hydroxypropyl MethylcelluloseHypromellose—
WaterWater—
MaltodextrinMaltodextrin—
StarchStarch—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin D — Granulomatous diseases (sarcoidosis, TB) — unregulated extra-renal CYP27B1 can cause life-threatening hypercalcemia even at standard doses [2][21]
3 Safety cross-reference
Vitamin D — Use with Caution
⚠ Hypercalcemia at >10,000 IU/day
⚠ Vascular calcification risk
Vitamin K — Limited Evidence
⚠ Critical interaction with warfarin
Sea Buckthorn — Generally Safe
⚠ May increase bleeding risk
⚠ May lower blood pressure
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
Nattokinase — Conditionally Safe
⚠ Anticoagulant/fibrinolytic effect
⚠ Increased bleeding risk
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID283355
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2023-03-22
6 More from Xtendlife
View Xtendlife Safety Scorecard → 11 products
Arthrit-EzeBone-ProtecCardio-KlenzCholest-NaturalDiabet-EzeFemale Rejuvenator7 Cite this page
Vancouver
Pkhakadze G. CX8 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 17]. Available from: https://supplement.ge/products/cx8-283355/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG